| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-10 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-08 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |